相关实验视频

Updated: Jun 28, 2025

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

大脑病理在大脑粉样血管病变中

Hsin-Hsi Tsai¹, Chia-Ju Liu², Bo-Ching Lee³

¹Department of Neurology, National Taiwan University Hospital, Taipei 100225, Taiwan.

Brain communications

|April 19, 2024

概括

陶病理在脑粉样血管病变 (CAA) 中比在小血管疾病中更常见. 与CAA相关的血管标志物,如表面性 siderosis,可能表明病理和阿尔茨海默病.

科学领域:

神经学神经学
神经成像是一种神经成像.
病理学病理学病理学

背景情况:

大脑粉样血管病变 (CAA) 是一种血管疾病,通常与阿尔茨海默氏症 (AD) 一起发生.
在CAA中病理的作用和特征尚未完全理解.
研究CAA中的tau负担对于了解疾病机制和潜在的治疗点至关重要.

研究的目的:

调查定子发射断层扫描 (PET) 和CAA之间的临床-放射学相关性.
为了比较可能患有CAA的患者与高血压小血管疾病 (SVD) 的tau负担.
在CAA中识别与tau病理相关的血管标记物.

主要方法:

使用11C-匹兹堡化合物B和18F-T807PET扫描来评估大脑粉样蛋白和病理.
包括可能患有CAA (n=31) 和高血压SVD (n=27) 的患者.
采用多变量回归模型来分析tau病理与临床/放射学特征之间的关联.

主要成果:

与SVD患者相比,CAA患者在下叶和Braak区域的脑负荷较高.
大脑病理与CAA相关的血管标志物显著相关,包括皮质表面 siderosis 和CAA得分,经过调整后.
病理与认知得分和海马体积有显著的相关性,即使在调整后.

结论:

病理在零星CAA中比在高血压SVD中更为普遍.
与CAA相关的血管病理,特别是皮质表面 siderosis,可能作为大脑 tau 病理的标志物.
研究结果表明,CAA和潜在的阿尔茨海默病病理学之间存在潜在的重叠.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.大脑粉样性血管病变 - 大脑粉样性血管病变皮层表面的 siderosis 皮层表面的 siderosis 脑内出血脑内出血小血管疾病是小血管疾病.

更多相关视频

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...